CHANNEL WEALTH LLC - CUE BIOPHARMA INC ownership

Quarter-by-quarter ownership
CHANNEL WEALTH LLC ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$35,190
-86.0%
15,300
-77.7%
0.02%
-86.1%
Q2 2023$250,755
+17.0%
68,700
+14.4%
0.14%
+4.3%
Q1 2023$214,37960,0500.14%
Other shareholders
CUE BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Prosight Management, LP 829,042$9,376,0005.61%
P.A.W. CAPITAL CORP 120,000$1,357,0001.24%
Nantahala Capital Management 2,539,700$28,724,0001.01%
Slate Path Capital LP 1,483,619$16,780,0000.88%
SANDERS MORRIS HARRIS LLC 359,113$4,416,0000.76%
APOGEM CAPITAL LLC 62,295$705,0000.46%
Robertson Stephens Wealth Management, LLC 478,500$5,411,0000.46%
Bleichroeder LP 200,000$2,262,0000.35%
ADVISORY RESEARCH INC 257,225$2,909,0000.23%
Granite Point Capital Management, L.P. 110,000$1,244,0000.21%
View complete list of CUE BIOPHARMA INC shareholders